Targeting host sialic acids in the upper respiratory tract with a broadly-acting neuraminidase to inhibit influenza virus transmission.

, can target host factors critical for transmission. Therefore, these broadly-acting neuraminidases have the potential to be the next generation of antivirals capable of preventing the spread of respiratory pathogens that rely on SA for infection.